Dr. Charney earned his MD at Icahn School of Medicine, where he remained to complete his PhD in conjunction with a residency in psychiatry. His expertise lies in the genetic architecture of neuropsychiatric illness, having been the lead bioinformatician on a large genome-wide association study of bipolar disorder, and played a lead role in developing a novel method that uses genetics to characterize the overlap between schizophrenia pathogenesis and antipsychotic mechanism of action. Alexander is also a primary investigator for the Living Brain Project, a multiscale, data-driven investigation of the human brain wherein a single living population is being studied using all of the tools available for human-subject neuroscience, including the powerful tools of molecular and cellular biology that to date have been applied primarily in the post-mortem setting.
